NCT07757412
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07757412
Title Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma. (ADAPTATION)
Acronym ADAPTATION
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Odense University Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries NOR | FIN | EST | DNK


No variant requirements are available.